Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence. 2017

Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
Department of Science, University Roma Tre, Rome, Italy.

Efflux pumps of the resistance-nodulation-cell-division (RND) family increase antibiotic resistance in many bacterial pathogens, representing candidate targets for the development of antibiotic adjuvants. RND pumps have also been proposed to contribute to bacterial infection, implying that efflux pump inhibitors (EPIs) could also act as anti-virulence drugs. Nevertheless, EPIs are usually investigated only for their properties as antibiotic adjuvants, while their potential anti-virulence activity is seldom taken into account. In this study it is shown that RND efflux pumps contribute to Pseudomonas aeruginosa PAO1 pathogenicity in an insect model of infection, and that the well-characterized EPI Phe-Arg-β-naphthylamide (PAβN) is able to reduce in vivo virulence of the P. aeruginosa PAO1 laboratory strain, as well as of clinical isolates. The production of quorum sensing (QS) molecules and of QS-dependent virulence phenotypes is differentially affected by PAβN, depending on the strain. Transcriptomic and phenotypic analyses showed that the protection exerted by PAβN from P. aeruginosa PAO1 infection in vivo correlates with the down-regulation of key virulence genes (e.g. genes involved in iron and phosphate starvation). Since PAβN impacts P. aeruginosa virulence, anti-virulence properties of EPIs are worthy to be explored, taking into account possible strain-specificity of their activity.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D015964 Gene Expression Regulation, Bacterial Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria. Bacterial Gene Expression Regulation,Regulation of Gene Expression, Bacterial,Regulation, Gene Expression, Bacterial
D059467 Transcriptome The pattern of GENE EXPRESSION at the level of genetic transcription in a specific organism or under specific circumstances in specific cells. Transcriptomes,Gene Expression Profiles,Gene Expression Signatures,Transcriptome Profiles,Expression Profile, Gene,Expression Profiles, Gene,Expression Signature, Gene,Expression Signatures, Gene,Gene Expression Profile,Gene Expression Signature,Profile, Gene Expression,Profile, Transcriptome,Profiles, Gene Expression,Profiles, Transcriptome,Signature, Gene Expression,Signatures, Gene Expression,Transcriptome Profile
D020869 Gene Expression Profiling The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell. Gene Expression Analysis,Gene Expression Pattern Analysis,Transcript Expression Analysis,Transcriptome Profiling,Transcriptomics,mRNA Differential Display,Gene Expression Monitoring,Transcriptome Analysis,Analyses, Gene Expression,Analyses, Transcript Expression,Analyses, Transcriptome,Analysis, Gene Expression,Analysis, Transcript Expression,Analysis, Transcriptome,Differential Display, mRNA,Differential Displays, mRNA,Expression Analyses, Gene,Expression Analysis, Gene,Gene Expression Analyses,Gene Expression Monitorings,Gene Expression Profilings,Monitoring, Gene Expression,Monitorings, Gene Expression,Profiling, Gene Expression,Profiling, Transcriptome,Profilings, Gene Expression,Profilings, Transcriptome,Transcript Expression Analyses,Transcriptome Analyses,Transcriptome Profilings,mRNA Differential Displays
D026901 Membrane Transport Proteins Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS. Biological Pump,Membrane Transport Protein,Membrane Transporter,Membrane Transporters,Metabolic Pump,Permease,Biological Pumps,Metabolic Pumps,Permeases,Pump, Biologic,Pump, Biological,Pump, Metabolic,Pumps, Biological,Pumps, Metabolic,Biologic Pump,Protein, Membrane Transport,Transport Protein, Membrane,Transport Proteins, Membrane,Transporter, Membrane,Transporters, Membrane

Related Publications

Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
September 2021, Antibiotics (Basel, Switzerland),
Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
August 2023, mBio,
Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
July 2008, Antimicrobial agents and chemotherapy,
Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
October 2009, Microbial pathogenesis,
Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
January 2022, Klinicheskaia laboratornaia diagnostika,
Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
June 2022, World journal of microbiology & biotechnology,
Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
October 2009, International journal of antimicrobial agents,
Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
February 2024, Antimicrobial agents and chemotherapy,
Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
September 2009, Current microbiology,
Giordano Rampioni, and Cejoice Ramachandran Pillai, and Francesca Longo, and Roslen Bondì, and Valerio Baldelli, and Marco Messina, and Francesco Imperi, and Paolo Visca, and Livia Leoni
May 2003, Biochemical and biophysical research communications,
Copied contents to your clipboard!